PCT vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

PCT

64.1
AI Score
VS
PCT Wins

GENI

47.6
AI Score

Investment Advisor Scores

PCT

64score
Recommendation
HOLD

GENI

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCT GENI Winner
Forward P/E 142.8571 62.5 GENI
PEG Ratio 0 0 Tie
Revenue Growth 173.5% 64.7% PCT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 64.1/100 47.6/100 PCT
Profit Margin 0.0% -23.0% PCT
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PCT 1M: -16.0% · 3M: -33.3% GENI 1M: -10.8% · 3M: -3.0%

Current Technical Phase

PCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.7%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $6.02

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.8 · Price: $6.82

Fundamentals Snapshot

Metric PCT GENI
Market Cap
Forward P/E -8.6 6.4
Trailing P/E
Revenue (TTM)
Revenue Growth 1.7% 0.6%
Gross Margin -7.8% 0.3%
Operating Margin -9.2% -0.1%
EPS -1.37 -0.64
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.